Literature DB >> 22361763

Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.

R P Lazarus1, S Kalaiselvan, K R John, J S Michael.   

Abstract

PURPOSE: Tuberculosis (TB) is endemic in India and the burden of multi-drug-resistant tuberculosis (MDR-TB) is high. Early detection of MDR-TB is of primary importance in controlling the spread of TB. The microscopic observational drug susceptibility (MODS) assay has been described as a cost-effective and rapid method by which mycobacterial culture and the drug susceptibility test (DST) can be done at the same time.
MATERIALS AND METHODS: A total of 302 consecutive sputum samples that were received in an accredited mycobacteriology laboratory for conventional culture and DST were evaluated by the MODS assay.
RESULTS: In comparison with conventional culture on Lowenstein Jensen (LJ) media, the MODS assay showed a sensitivity of 94.12% and a specificity of 89.39% and its concordance with the DST by the proportion method on LJ media to isoniazid and rifampicin was 90.8% and 91.5%, respectively. The turnaround time for results by MODS was 9 days compared to 21 days by culture on LJ media and an additional 42 days for DST by the 1% proportion method. The cost of performing a single MODS assay was Rs. 250/-, compared to Rs. 950/- for culture and 1st line DST on LJ.
CONCLUSION: MODS was found to be a sensitive and rapid alternative method for performing culture and DST to identify MDR-TB in resource poor settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361763     DOI: 10.4103/0255-0857.93039

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  7 in total

1.  Performance of solid and liquid culture media for the detection of Mycobacterium tuberculosis in clinical materials: meta-analysis of recent studies.

Authors:  F Rageade; N Picot; A Blanc-Michaud; S Chatellier; C Mirande; E Fortin; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-24       Impact factor: 3.267

2.  Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.

Authors:  M Sanogo; B Kone; B Diarra; M Maiga; B Baya; A M Somboro; Y S Sarro; A C G Togo; B P P Dembele; D Goita; A Kone; O M'Baye; N Coulibaly; S Diabate; B Traore; M H Diallo; Y I Coulibaly; P Saleeb; M Belson; S Orsega; S Siddiqui; M A Polis; S Dao; R L Murphy; S Diallo
Journal:  Clin Microbiol Infect       Date:  2017-01-18       Impact factor: 8.067

3.  Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.

Authors:  Irina Kontsevaya; Jim Werngren; Yen Holicka; Kadri Klaos; Anh Tran; Vladyslav Nikolayevskyy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-30       Impact factor: 3.267

4.  Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis.

Authors:  A Agarwal; C D S Katoch; M Kumar; T N Dhole; Y K Sharma
Journal:  Med J Armed Forces India       Date:  2018-05-28

5.  Concurrent evaluation of microscopic observation of drug susceptibility assay for pulmonary and extrapulmonary tuberculosis.

Authors:  Sonali Sudhir Zadbuke; Reena Set; Nishat Khan; Jayanthi Shastri
Journal:  J Lab Physicians       Date:  2017 Apr-Jun

6.  Early and efficient detection of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures.

Authors:  Benson R Kidenya; Rodrick Kabangila; Robert N Peck; Stephen E Mshana; Lauren E Webster; Serena P Koenig; Warren D Johnson; Daniel W Fitzgerald
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 7.  Rapid culture-based diagnosis of pulmonary tuberculosis in developed and developing countries.

Authors:  Shady Asmar; Michel Drancourt
Journal:  Front Microbiol       Date:  2015-11-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.